Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Nathalie Zeitouni, MD
Medical Dermatology Specialists; Phoenix, Arizona, United States
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alliance Dermatology & Mohs Center
Phoenix, Arizona, United States
- Medical Dermatology Specialists
Phoenix, Arizona, United States
- Dermatology Practice
Greenwood Village, Colorado, United States
- Dermatology Associates Pa of the Palm Beaches
Delray Beach, Florida, United States
- Gwinnett Clinical Research Center, Inc.
Snellville, Georgia, United States
- Laser and Skin Surgery Center of Indiana
Indianapolis, Indiana, United States
- the Indiana Clinical Trials Center, Pc
Plainfield, Indiana, United States
- Delricht Research
Baton Rouge, Louisiana, United States
- Skin Search of Rochester, Inc.
Rochester, New York, United States
- Rochester Dermatologic Surgery
Victor, New York, United States
- Clinical Research Center of the Carolinas
Charleston, South Carolina, United States
- Dermresearch, P.A.
Austin, Texas, United States
- Austin Institute for Clinical Research
Houston, Texas, United States
- Austin Institute for Clinical Research Inc.
Pflugerville, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Dec 2022
- Primary completion
- 3 Sept 2025
- Completion
- 1 Jul 2026
- Last update posted
- 21 Aug 2026
- Registered enrollment
- 172
- Registry id
- NCT05662202
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.